Ignite Creation Date:
2025-12-24 @ 12:44 PM
Ignite Modification Date:
2025-12-27 @ 9:38 PM
Study NCT ID:
NCT00787761
Status:
COMPLETED
Last Update Posted:
2012-10-01
First Post:
2008-11-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer
Sponsor:
Northside Hospital, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-04
Start Date Type:
None
Primary Completion Date:
2010-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-05
Completion Date Type:
ACTUAL
First Submit Date:
2008-11-07
First Submit QC Date:
None
Study First Post Date:
2008-11-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-07-09
Results First Submit QC Date:
None
Results First Post Date:
2012-10-01
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-08-29
Last Update Post Date:
2012-10-01
Last Update Post Date Type:
ESTIMATED